Synta Pharmaceuticals Corp

About Us
Pipeline
- Overview
- Ganetespib
- Elesclomol
- STA-9584
- IL-12/IL-13
- CRACM
Clinical Trials
- Overview
- Trials by Tumor Type
- Synta-Sponsored Trials
  - GALAXY
  - ENCHANT
  - CHIARA
  - Elesclomol
- Investigator-Sponsored Trials
Investors
News & Events
- Press Releases
- Webcasts & Events
Careers

Contact Us

Targeting the Molecular Chaperone in Cancer

Synta Clinical Trials

Synta Corporate Presentation
Interim Results of the GALAXY-1 Phase 2b/3 Trial
ESMO 2012
Reception Webcast
25th Annual ROTH Conference

©2013 Synta Pharmaceuticals About Us | Pipeline | Clinical Trials | Investors | News and Events | Careers | Contact | Terms of Use Site Credits

The use of this site is governed by the Terms of Use. By using this site you acknowledge that you have read the Terms of Use and the disclaimers and caveats contained in this site, and that you accept and agree to be bound by the terms thereof.